Wegovy Doses: How Dosing Works and What to Expect

Wegovy doses are not the same throughout treatment: they start low and increase in steps so your body can adjust and side effects are easier to manage. That structure is deliberate, and the exact dose schedule is not self-set. It is decided by the prescriber managing your treatment and set out in the patient information leaflet supplied with your medicine.

For adults in the UK who have been prescribed Wegovy and want to understand how dose changes work in practice, the reason for this gradual increase is tolerance rather than speed. Starting at the full dose would cause far more nausea and digestive upset than most people could manage, which is why following the prescribed schedule matters for safe, effective use and why changing doses yourself or restarting incorrectly after a break can cause problems.

This page explains how Wegovy dosing works, what tends to happen at each stage, why doses are escalated, who decides what and when, how side effects are managed, and what to do if things do not go to plan, including missed doses, dose holds, restarting treatment, safety precautions, and where to find your individual dosing information.

Key things to know

• Wegovy treatment usually starts at a low dose, which is increased gradually according to the prescribed schedule.
• Your prescriber decides when your dose should increase and whether an adjustment is needed.
• Gastrointestinal side effects may become more noticeable after starting treatment or increasing the dose, although experiences vary.
• Not everyone follows the same treatment pathway. Your prescriber may delay an increase or adjust treatment if side effects are difficult to manage.
• A higher dose does not automatically mean better results for every individual.
• Never change your dose, double up after a missed injection or restart after a prolonged break without appropriate advice.
• Check your patient information leaflet and consult your prescriber or pharmacist if you are unsure what to do.

Why is Wegovy given in increasing doses?

Wegovy is increased gradually to help reduce gastrointestinal side effects, such as nausea, vomiting and diarrhoea. Starting at a low dose gives your body time to adjust. Increasing the dose faster than recommended may make these side effects more difficult to manage, so it is important to follow your prescribed schedule.

This is why moving up faster than the product information allows is counterproductive. It increases side effects without improving the result, and it makes people more likely to stop treatment altogether.

What do the different stages mean?

The starting dose of Wegovy for adults is usually 0.25 mg once weekly. The dose is normally increased every four weeks, provided treatment is tolerated and the prescriber considers the increase appropriate.

For adult weight management, 2.4 mg once weekly is the standard maintenance dose. If significant gastrointestinal side effects occur, the prescriber may delay an increase or temporarily return to the previous dose, as appropriate.

A higher maintenance dose of 7.2 mg once weekly may be considered for eligible adults with obesity under the authorised UK prescribing guidance. It is not a routine next step for everyone.

Who decides your dose?

Your prescriber does, following a clinical assessment and at every review afterwards, because Wegovy is a prescription medication for chronic weight management and the doctor determines the safest Wegovy dosage and overall treatment plan for you. This is not a decision patients make for themselves, and it is not a fixed sequence that runs automatically.

The assessment considers your medical history, your other conditions, the other medicines you take, and, while mild-to-moderate kidney or liver impairment does not usually require dose adjustment, your prescriber still reviews the full clinical picture and how you are responding. Blood sugar medicines may need adjustment when starting Wegovy, and it should not be combined with another GLP-1 receptor agonist. At each review, your prescriber decides whether to step up, hold where you are, or take another approach.

Treatment suitability depends on an individual clinical assessment, and your prescriber will determine the appropriate treatment the doctor prescribes. Wegovy should only be used under the supervision of an appropriately qualified prescriber. Results vary between individuals.

What might make a prescriber hold a dose rather than increase it?

Several things, and none of them mean treatment has failed:

• Side effects that have not settled from the previous step, especially when patients should be monitored closely for side effects during titration before deciding whether to hold or increase
• Difficulty eating or drinking normally
• Ongoing vomiting or diarrhoea
• A new symptom that needs investigating first
• A change in your other medicines or health
• Weight and health markers responding well where you are
• Your own preference, discussed and agreed

Holding a dose is a normal part of managing treatment. Wegovy treatment is often adjusted step by step, and Wegovy depends on how well side effects are tolerated at that point in the schedule. If your prescriber suggests holding where you are, that can be part of the plan while they monitor side effects and how the body adjusts before the next review, rather than meaning something has gone wrong.

What happens at each stage of treatment?

The experience follows a fairly consistent pattern, even though the specifics differ between people.

Starting out

Wegovy treatment usually begins at 0.25 mg once weekly. Some people notice changes in appetite or fullness early in treatment, while others experience these changes more gradually.

The starting dose is intended to help your body adjust rather than deliver the full treatment effect. Weight changes at this stage can vary, so a modest early result does not necessarily mean the medicine is not working.

Eating smaller portions, eating slowly and maintaining adequate fluid intake may help. Contact your healthcare professional if you cannot keep fluids down or develop severe abdominal pain.

After a dose increase

Gastrointestinal side effects can become more noticeable after a dose increase, although the timing and severity vary from person to person. Eating smaller portions and choosing foods that are easier to tolerate may help.

If symptoms are severe, persistent or interfere with eating and drinking, contact your prescriber rather than continuing to increase the dose without advice.

On a maintenance dose

With the usual adult dosing schedule, the 2.4 mg maintenance dose is reached from week 17, provided treatment is tolerated and the prescriber considers the increase appropriate. Some people need more time because of side effects or other clinical considerations.

Once you reach a maintenance dose, your prescriber will continue to review your response and tolerability. Eating patterns, physical activity, adequate nutrition and sleep remain important parts of long-term weight management.

Check the label and instructions for your specific pen rather than assuming that every Wegovy pen contains the same number of doses.

If you cannot tolerate an increase

Tell your prescriber rather than pushing through or stopping on your own. There are usually options short of ending treatment.

Do not reduce, split or skip doses to manage side effects yourself. Changing how a medicine is taken without advice can affect both safety and outcome.

Is a higher dose better?

A higher dose is not automatically the right choice for everyone. Some eligible adults may benefit from additional weight loss at a higher authorised dose, but the potential benefits must be weighed against side effects and individual circumstances.

Your prescriber will assess whether an increase is appropriate. Do not compare your dose with someone else's or request a faster increase simply to try to speed up weight loss.

If your dose needs to be held or adjusted because of side effects, discuss the next steps with your prescriber rather than treating it as a setback.

Missed doses, breaks and restarting

These situations are common and the rules are specific, so they are worth understanding before they happen.

What if I miss a dose?

If you miss a Wegovy injection, follow the missed-dose instructions in your patient information leaflet. Under the usual UK instructions, take the missed dose as soon as possible within five days of the scheduled dose. If more than five days have passed, skip it and take your next dose on the usual day. Never take a double dose to make up for one you missed.

If you miss several doses or have had a prolonged break, speak to your prescriber before restarting. Depending on the length of the interruption and your circumstances, you may need to restart at a lower dose and increase gradually again.

If you need to change your injection day, check the minimum interval required between injections in your leaflet. If your supply is interrupted, contact your pharmacy or prescriber rather than trying to obtain the medicine from an unregulated source.

Can I change which day I inject?

The leaflet sets out the conditions for changing your injection day, including the minimum gap that must be left between doses. Wegovy injections are usually taken on the same day each week, and if you change that day you should still follow the leaflet’s minimum-gap rule. Check it before changing anything, or ask your pharmacist.

Do not simply change the day of your weekly injection to make a new schedule work.

What if I stop for a while and want to restart?

Speak to your prescriber before restarting. After a break, treatment may need to begin again at a lower dose and be built back up, because tolerance fades.

Restarting at the dose you were on before a gap can cause significant side effects. This is one of the more common ways people get into difficulty, and it is entirely avoidable.

What if I run out or my supply is interrupted?

Contact your prescriber or pharmacy as early as you can, rather than waiting until you have missed doses. An interruption may change what happens next.

Do not obtain the medicine from outside the regulated system to bridge a gap. Medicines bought without a prescription or from outside UK regulation are not covered by MHRA oversight, and their contents, strength and storage cannot be relied on.

Where to find the doses that apply to you

Three sources, in this order.

1. The patient information leaflet inside your pack. This is the definitive reference for your medicine, including doses, intervals, missed dose rules and storage. Read it when you collect your prescription rather than when something goes wrong.
2. The labelling on the pen itself, which states the dose it delivers. Check it every time, particularly around an increase, since this is where mix-ups happen.
3. Your prescriber and pharmacist, who can explain what applies to you specifically and answer anything the leaflet does not make clear.

If you have been given a written plan by your prescriber, that plan and the leaflet should agree. If they do not, do not guess. Ask before injecting.

Safety points around dose changes

Before every injection, check that you have the correct medicine and pen. Follow the instructions for your specific product and rotate injection sites as directed.

If you develop persistent vomiting or severe diarrhoea, ask your prescriber or pharmacist whether this could affect any oral medicines you take, including oral contraceptives.

Tell your healthcare team that you use Wegovy before a procedure involving sedation or general anaesthesia. Because semaglutide delays stomach emptying, the team can assess whether additional precautions are needed.

Seek urgent medical attention if you develop severe, persistent abdominal pain, particularly if it spreads to your back, with or without nausea or vomiting. This may indicate pancreatitis. If pancreatitis is suspected, follow urgent medical advice and do not restart Wegovy if pancreatitis is confirmed, in line with the product information.

Suspected side effects can also be reported through the MHRA Yellow Card scheme.

Medical Disclaimer

This article is for general information only. It is not a substitute for medical advice, the patient information leaflet supplied with your medicine or an individual assessment by a qualified healthcare professional.

Wegovy is a prescription-only medicine in the UK. Its suitability, dose and treatment schedule depend on your individual circumstances and the applicable prescribing guidance. Do not start, stop, change or restart treatment without advice from your prescriber.

Seek urgent medical attention if you develop severe, persistent abdominal pain, swelling of the face, lips, tongue or throat, difficulty breathing, or signs of significant dehydration.

Suspected side effects can be reported through the MHRA Yellow Card scheme.